Abstract |
Plasma levels of the major norepinephrine (NE) metabolite, 3-methoxy-4-hydroxyphenylglycol ( MHPG), were measured in a rapidly cycling bipolar patient and her first-degree relatives. The mood state dependence and the reciprocal relationship between noradrenergic and cholinergic activity were investigated by assessing mood, thought disorder, and plasma MHPG following the infusion of physostigmine. A correlation was found between plasma MHPG and mood states, with exceedingly high levels during mania and hypomania. Levels were significantly decreased by ECT or combined lithium and chlorpromazine administration. A pathologic diurnal MHPG pattern was detected during periods of abnormal mood changes. Infusion of physostigmine led to a prompt reduction in MHPG release and a marked decline in mood-state measurements and the overall level of thought disorder. Muscarinic receptors exerting negative feedback control over the synthesis and/or release of NE may have become supersensitive as a consequence of alpha 2-adrenoceptor densensitization.
|
Authors | D Ostrow, A Halaris, M Dysken, E DeMet, M Harrow, J Davis |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 45
Issue 7
Pg. 306-9
(Jul 1984)
ISSN: 0160-6689 [Print] United States |
PMID | 6539774
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Glycols
- Receptors, Adrenergic
- Receptors, Muscarinic
- Methoxyhydroxyphenylglycol
- Lithium
- Physostigmine
- Chlorpromazine
- Norepinephrine
|
Topics |
- Adolescent
- Adult
- Bipolar Disorder
(blood, genetics, psychology)
- Chlorpromazine
(pharmacology)
- Circadian Rhythm
- Electroconvulsive Therapy
- Feedback
- Female
- Glycols
(blood)
- Humans
- Lithium
(pharmacology)
- Male
- Methoxyhydroxyphenylglycol
(blood)
- Middle Aged
- Norepinephrine
(metabolism)
- Physostigmine
(pharmacology)
- Receptors, Adrenergic
(drug effects)
- Receptors, Muscarinic
(drug effects)
|